Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Schnabel

Showing results (201-210 of 346) with videos related to

Pageof 35
Sort By:
Circulation|May 26, 2010
Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker projectStefan Blankenberg, Tanja Zeller, Olli Saarela, et al.
European Stroke Journal|January 30, 2026
Update on left atrial appendage closure for neurologistsKarl Georg Haeusler, Luciano A Sposato, Marek Grygier, et al.
Journal of the American College of Cardiology|September 17, 2025
Outcomes and Management of Stressor-Associated Atrial Fibrillation: JACC State-of-the-Art ReviewJulian S Haimovich, Shinwan Kany, Ezimamaka Ajufo, et al.
Cardiovascular Research|June 2, 2023
Association of genetic risk and outcomes in patients with atrial fibrillation: interactions with early rhythm control in the EAST-AFNET4 trialShinwan Kany, Christoph Al-Taie, Carolina Roselli, et al.
Scientific Reports|June 1, 2026
Holter-ECG findings after acute ischemic stroke and TIA: A systematic analysis of the MonDAFIS randomized trialNiklas Thießen, Manuel C Olma, Serdar Tütüncü, et al.
JAMA Cardiology|July 30, 2025
Diabetes and Obesity and Treatment Effect of Early Rhythm Control vs Usual Care in Patients With Atrial Fibrillation: A Secondary Analysis of the EAST-AFNET 4 Randomized Clinical TrialAndreas Metzner, Stephan Willems, Katrin Borof, et al.
European Journal of Epidemiology|September 21, 2014
BiomarCaRE: rationale and design of the European BiomarCaRE project including 300,000 participants from 13 European countriesTanja Zeller, Maria Hughes, Tarja Tuovinen, et al.
ESC Heart Failure|November 26, 2021
Chronic kidney disease and risk of atrial fibrillation and heart failure in general population-based cohorts: the BiomarCaRE projectMartin Rehm, Dietrich Rothenbacher, Licia Iacoviello, et al.
ESC Heart Failure|September 6, 2021
Gender differences in characteristics and outcomes in heart failure patients referred for end-stage treatmentNina Fluschnik, Felix Strangl, Christoph Kondziella, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 23, 2026
Interactions of blood biomolecules with early rhythm control in atrial fibrillation patients: Exploratory analysis of the EAST-AFNET 4 Biomolecule StudyChristoph Al-Taie, Julius Obergassel, Katrin Borof, et al.
Pageof 35

Showing results (201-210 of 346) with videos related to

Sort By:
Pageof 35
Circulation|May 26, 2010
Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker projectStefan Blankenberg, Tanja Zeller, Olli Saarela, et al.
European Stroke Journal|January 30, 2026
Update on left atrial appendage closure for neurologistsKarl Georg Haeusler, Luciano A Sposato, Marek Grygier, et al.
Journal of the American College of Cardiology|September 17, 2025
Outcomes and Management of Stressor-Associated Atrial Fibrillation: JACC State-of-the-Art ReviewJulian S Haimovich, Shinwan Kany, Ezimamaka Ajufo, et al.
Cardiovascular Research|June 2, 2023
Association of genetic risk and outcomes in patients with atrial fibrillation: interactions with early rhythm control in the EAST-AFNET4 trialShinwan Kany, Christoph Al-Taie, Carolina Roselli, et al.
Scientific Reports|June 1, 2026
Holter-ECG findings after acute ischemic stroke and TIA: A systematic analysis of the MonDAFIS randomized trialNiklas Thießen, Manuel C Olma, Serdar Tütüncü, et al.
JAMA Cardiology|July 30, 2025
Diabetes and Obesity and Treatment Effect of Early Rhythm Control vs Usual Care in Patients With Atrial Fibrillation: A Secondary Analysis of the EAST-AFNET 4 Randomized Clinical TrialAndreas Metzner, Stephan Willems, Katrin Borof, et al.
European Journal of Epidemiology|September 21, 2014
BiomarCaRE: rationale and design of the European BiomarCaRE project including 300,000 participants from 13 European countriesTanja Zeller, Maria Hughes, Tarja Tuovinen, et al.
ESC Heart Failure|November 26, 2021
Chronic kidney disease and risk of atrial fibrillation and heart failure in general population-based cohorts: the BiomarCaRE projectMartin Rehm, Dietrich Rothenbacher, Licia Iacoviello, et al.
ESC Heart Failure|September 6, 2021
Gender differences in characteristics and outcomes in heart failure patients referred for end-stage treatmentNina Fluschnik, Felix Strangl, Christoph Kondziella, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 23, 2026
Interactions of blood biomolecules with early rhythm control in atrial fibrillation patients: Exploratory analysis of the EAST-AFNET 4 Biomolecule StudyChristoph Al-Taie, Julius Obergassel, Katrin Borof, et al.
Pageof 35